Virginia medical technology developer K2M announced on Wednesday that it will raise $40 million from stock sales, eight months after its $132 million IPO. The Leesburg-based company has developed ways of treating spinal diseases with devices for minimally invasive surgery for about a decade. The company posted a revenue of nearly $158 million, a loss of a little less than $38 million in the last fiscal year.
Help employers find you! Check out all the jobs and post your resume.
